FindTrial
Sign In

Albuminuria increased risk of left ventricular hypertrophy in type 2 diabetes patients with early renal insufficiency

Albuminuria increased risk of left ventricular hypertrophy in type 2 diabetes patients with early renal insufficiency

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000038318
Enrollment
Unknown
Registered
2020-09-17
Start date
2018-07-01
Completion date
Unknown
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Case series:Nil

Sponsors

Medical Ethics Committee of Affiliated Nanhai Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients were diagnosed as T2DM base on WHOs Diabetes Diagnostic Criteria, 1999; 2. Patients were recruited from National Metabolic Management Center (MMC) and Department of Endocrinology, Nanhai Peoples Hospital, the Second School of Clinical Medicine, Southern Medical University, between July 2018 and March 2019.

Exclusion criteria

Exclusion criteria: Patients had history and symptoms of heart failure (chest pain, dyspnea, malignant arrhythmia), cerebrovascular, renal failure.

Design outcomes

Primary

MeasureTime frame
Fasting insulin;albuminuria/urine creatinine ratio;Renal function;Insulin sensitivity;left ventricular mass;left ventricular end-diastolic diameter;left ventricular end-diastolic diameter;—

Countries

China

Contacts

Public ContactYi Shu

Department of Endocrinology, Nanhai People’s Hospital

sy1973@163.com+86 13929976496

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026